|
Handok Pharmaceuticals Co., Ltd. - Comparative Business Analysis Snapshot
Business Description
Handok Pharmaceuticals Co., Ltd.. The Company's principal activities are manufacturing and distributing over-the-counter medicines. The Company's products include Amaryl for diabetes, Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular disease, Teveten for essential hypertension, Festal for dyspepsia, Munobal for hypertension and stenocardia, Triapin for essential hypertension, Gatiflo for respiratory and other infective disease, Lasix for hypertension and edema, Ketas for disturbance of cerebral circulation and Dermatop for dermatology. In addition, the Company offers reagents and diagnostic instruments. It is also engaged in the real estate leasing business. The Company operates a research laboratory in Seoul and a plant in Chungcheongbuk-Do, Korea.
Competitor Analysis
This analysis compares Handok Pharmaceuticals Co., Ltd. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
